(ZEAL) Zealand Pharma - Performance -26% in 12m
Compare ZEAL with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
34.73%
#17 in Group
Rel. Strength
23.04%
#6140 in Universe
Total Return 12m
-25.95%
#76 in Group
Total Return 5y
103.18%
#22 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG 0.31
71th Percentile in Group
FCF Yield -3.16%
(?) Percentile in Group
12m Total Return: ZEAL (-26%) vs XBI (-5.4%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
-4.25% | 15.2% | 163% | 12.1 | 10.6 | 1.43 | 81.5% | 18.5% |
HLN NYSE Haleon |
2.64% | 25.8% | 43.6% | 24.4 | 20.2 | 1.79 | 64.4% | 6.58% |
AMGN NASDAQ Amgen |
-7.54% | 5.43% | 43.3% | 38.5 | 13.8 | 0.97 | -42.0% | -25.9% |
LONN SW Lonza |
8.68% | 15.4% | 38.7% | 65.8 | 33.6 | 1.23 | 12.6% | -10.3% |
BIM PA Biomerieux |
2.77% | 21.2% | 8.84% | 31 | 24.2 | 1.45 | -58.7% | -25.1% |
KMDA NASDAQ Kamada |
-1.94% | 25.9% | -9.16% | 26.6 | 24 | 0.96 | 80.4% | 43% |
ERF PA Eurofins Scientific SE |
15.4% | 0.42% | 17.2% | 26.6 | 13.6 | 0.56 | -67.4% | -17.7% |
BMRN NASDAQ Biomarin Pharmaceutical |
-7.7% | -24.7% | -30.6% | 28.6 | 15.9 | 0.43 | 67.5% | 59.7% |
Performance Comparison: ZEAL vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ZEAL
Total Return (including Dividends) | ZEAL | XBI | S&P 500 |
---|---|---|---|
1 Month | 0.15% | 5.55% | -0.45% |
3 Months | -34.06% | -9.75% | -6.29% |
12 Months | -25.95% | -5.39% | 13.04% |
5 Years | 103.18% | -13.20% | 111.82% |
Trend Score (consistency of price movement) | ZEAL | XBI | S&P 500 |
1 Month | -20.3% | 70% | 47.5% |
3 Months | -90.7% | -88.1% | -87.3% |
12 Months | -46.1% | -44.4% | 54.3% |
5 Years | 64.2% | -53.6% | 84.2% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #125 | -5.12% | 0.60% |
3 Month | #151 | -26.9% | -29.6% |
12 Month | #75 | -21.7% | -34.5% |
5 Years | #21 | 134% | -4.08% |
FAQs
Does ZEAL Zealand Pharma outperforms the market?
No,
over the last 12 months ZEAL made -25.95%, while its related Sector, the SPDR S&P Biotech (XBI) made -5.39%.
Over the last 3 months ZEAL made -34.06%, while XBI made -9.75%.
Over the last 3 months ZEAL made -34.06%, while XBI made -9.75%.
Performance Comparison ZEAL vs Indeces and Sectors
ZEAL vs. Indices ZEAL is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 7.61% | 0.60% | -42.9% | -39.0% |
US NASDAQ 100 | QQQ | 6.69% | -1.75% | -43.6% | -40.9% |
US Dow Jones Industrial 30 | DIA | 8.15% | 3.0% | -42.1% | -35.2% |
German DAX 40 | DAX | 7.97% | 0.37% | -60.9% | -51.0% |
Shanghai Shenzhen CSI 300 | CSI 300 | 11.3% | 3.36% | -39.2% | -30.9% |
Hongkong Hang Seng | HSI | 8.01% | 1.67% | -43.4% | -38.9% |
India NIFTY 50 | INDA | 10.1% | -4.73% | -42.7% | -28.9% |
Brasil Bovespa | EWZ | 9.24% | -2.68% | -48.6% | -19.2% |
ZEAL vs. Sectors ZEAL is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 7.46% | 0.75% | -48.8% | -49.4% |
Consumer Discretionary | XLY | 7.58% | 0.74% | -44.0% | -40.6% |
Consumer Staples | XLP | 9.67% | 0.97% | -47.0% | -36.9% |
Energy | XLE | 11.9% | 14.2% | -37.7% | -16.6% |
Financial | XLF | 8.72% | 2.16% | -49.8% | -48.6% |
Health Care | XLV | 10.3% | 4.82% | -37.7% | -24.7% |
Industrial | XLI | 7.29% | -0.15% | -43.9% | -36.6% |
Materials | XLB | 9.42% | 3.37% | -35.0% | -21.5% |
Real Estate | XLRE | 7.72% | 1.25% | -43.0% | -44.3% |
Technology | XLK | 6.05% | -2.28% | -39.9% | -36.4% |
Utilities | XLU | 8.89% | 0.05% | -47.3% | -46.7% |
Aerospace & Defense | XAR | 6.58% | -6.83% | -56.7% | -53.4% |
Biotech | XBI | 7.77% | -5.40% | -27.5% | -20.6% |
Homebuilder | XHB | 8.88% | 2.23% | -27.9% | -19.8% |
Retail | XRT | 8.85% | 1.31% | -36.9% | -24.4% |